Skip to main content

Research Repository

Advanced Search

Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) and serine biosynthetic pathway genes are co-ordinately increased during anabolic agent-induced skeletal muscle growth

Brown, David M.; Williams, Hannah; Ryan, K.J.P.; Wilson, T.L.; Daniel, Zoe C.T.R.; Mareko, M. H. D.; Emes, Richard D.; Harris, D. W.; Wattis, Jonathan A.D.; Dryden, Ian L.; Hodgman, T. C.; Brameld, John M.; Parr, Tim

Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) and serine biosynthetic pathway genes are co-ordinately increased during anabolic agent-induced skeletal muscle growth Thumbnail


Authors

David M. Brown

Hannah Williams

K.J.P. Ryan

T.L. Wilson

Zoe C.T.R. Daniel

M. H. D. Mareko

Richard D. Emes

D. W. Harris

JONATHAN WATTIS jonathan.wattis@nottingham.ac.uk
Professor of Applied Mathematics

Ian L. Dryden

T. C. Hodgman

Profile Image

JOHN BRAMELD JOHN.BRAMELD@NOTTINGHAM.AC.UK
Professor of Nutritional Biochemistry

TIM PARR TIM.PARR@NOTTINGHAM.AC.UK
Professor of Nutritional Biochemistry



Abstract

We aimed to identify novel molecular mechanisms for muscle growth during administration of anabolic agents. Growing pigs (Duroc/(Landrace/Large-White)) were administered Ractopamine (a beta-adrenergic agonist; BA; 20 ppm in feed) or Reporcin (recombinant growth hormone; GH; 10 mg/48 hours injected) and compared to a control cohort (feed only; no injections) over a 27-day time course (1, 3, 7, 13 or 27-days). Longissimus Dorsi muscle gene expression was analyzed using Agilent porcine transcriptome microarrays and clusters of genes displaying similar expression profiles were identified using a modified maSigPro clustering algorithm. Anabolic agents increased carcass (p = 0.002) and muscle weights (Vastus Lateralis: p < 0.001; Semitendinosus: p = 0.075). Skeletal muscle mRNA expression of serine/one-carbon/glycine biosynthesis pathway genes (Phgdh, Psat1 and Psph) and the gluconeogenic enzyme, phosphoenolpyruvate carboxykinase-M (Pck2/PEPCK-M), increased during treatment with BA, and to a lesser extent GH (p < 0.001, treatment x time interaction). Treatment with BA, but not GH, caused a 2-fold increase in phosphoglycerate dehydrogenase (PHGDH) protein expression at days 3 (p < 0.05) and 7 (p < 0.01), and a 2-fold increase in PEPCK-M protein expression at day 7 (p < 0.01). BA treated pigs exhibit a profound increase in expression of PHGDH and PEPCK-M in skeletal muscle, implicating a role for biosynthetic metabolic pathways in muscle growth.

Journal Article Type Article
Acceptance Date Jun 8, 2016
Online Publication Date Jun 28, 2016
Publication Date Jun 28, 2016
Deposit Date Aug 1, 2016
Publicly Available Date Aug 1, 2016
Journal Scientific Reports
Electronic ISSN 2045-2322
Publisher Nature Publishing Group
Peer Reviewed Peer Reviewed
Volume 6
Issue 1
DOI https://doi.org/10.1038/srep28693
Keywords Pck2; PHGDH; Beta-adrenergic agonist; Growth hormone; Porcine; Muscle
Public URL https://nottingham-repository.worktribe.com/output/793169
Publisher URL http://www.nature.com/articles/srep28693

Files





You might also like



Downloadable Citations